Drug profile · INN
antazoline phosphate
VASOCON-A
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
antazoline phosphate (VASOCON-A) is an FDA-listed pharmaceutical active ingredient. Route of administration: ophthalmic. Current US regulatory status: approved.
Key facts
INN antazoline phosphate
Brand VASOCON-A
Route OPHTHALMIC
Formulation SOLUTION/DROPS
Frequently asked questions
What is antazoline phosphate?
antazoline phosphate (VASOCON-A) is an FDA-listed pharmaceutical active ingredient. Route of administration: ophthalmic. Current US regulatory status: approved.
What is the brand name for antazoline phosphate?
VASOCON-A is a marketed brand name for antazoline phosphate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of antazoline phosphate?
antazoline phosphate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.